Hepatitis Now: Defining Optimal Treatment Duration in HBV

On May 21, join us for the second Webinar in a series reviewing best practices and emerging data in viral hepatitis.

In this live, 45-minute, CME/CE/CPE-certified Webinar, Robert S. Brown, Jr., MD, MPH, will review metrics that determine when to initiate therapy for chronic hepatitis B, criteria for optimal drug selection, and guidance on treatment withdrawal.

Agenda

Welcome and Program Overview

  • When to start HBV therapy
  • What drugs to use
  • When to stop HBV therapy

Question and Answer Session

Events

Date / Time
Event Details

Faculty

Faculty
Robert S. Brown, Jr., MD, MPH

Gladys and Roland Harriman Professor of Medicine
Vice Chair,
Transitions of Care
Clinical Chief, Division of Gastroenterology and Hepatology
Weill Cornell Medicine
New York, New York

Goal Statement
The goal of this activity is to improve participants’ confidence and competence in incorporating best practices and emerging data into their patient care strategies for patients with viral hepatitis.

Target Audience 
This program is intended forphysicians, registered nurses, pharmacists, and other healthcare professionals involved in the management of patients with viral hepatitis.

Learning Objectives 

  • Implement updated strategies for management of HBV infection based on available treatment options and expert guidelines

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this activity is 0.75 contact hour.

Pharmacist Continuing Education
CCO designates this continuing education activity for 0.75 contact hour (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-19-017-L01-P.

Type of Activity: Application

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.